Vicagrel

Metabolites - Vicagrel is an oral antiplatelet agent developed to prevent thrombotic cardiovascular events by inhibiting platelet aggregation through P2Y12 receptor blockade. Reference standards of Vicagrel API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Vicagrel
    [catalogue_number] => PA 22 1270000
    [category_ids] => ,78,75,70,76,82,
    [chemical_name] => 
    [weight] => 379.86
    [form] => C18H18ClNO4S
    [cas] => 1314081-53-2
    [pslug] => 1314081-53-2-vicagrel-pa221270000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 22 1270000
PA 22 1270000

Vicagrel


  • Catalogue No.:PA 22 1270000

  • CAS :

    1314081-53-2

  • Molecular Formula : C18H18ClNO4S

  • Molecular Weight : 379.86

Details
pharmaffiliates
-->